Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

P. Soelberg Sørensen; C. Ross; K.M. Clemmensen; K. Bendtzen; J.L. Frederiksen; K. Jensen; O. Kristensen; T. Petersen; S. Rasmussen; M. Ravnborg; Egon Stenager; N. Koch-Henriksen

doi:10.1016/S0140-6736(03)14541-2

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

P. Soelberg Sørensen
, C. Ross
, K.M. Clemmensen
, K. Bendtzen
, J.L. Frederiksen
, K. Jensen
, O. Kristensen
, T. Petersen
, S. Rasmussen
, M. Ravnborg
, Egon Stenager
, N. Koch-Henriksen

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	The Lancet
Volume	362
Issue number	9391
Pages (from-to)	1184-91
ISSN	0140-6736
DOIs	https://doi.org/10.1016/S0140-6736(03)14541-2
Publication status	Published - 2003

Documents & Links

10.1016/S0140-6736(03)14541-2

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Soelberg Sørensen, P., Ross, C., Clemmensen, K. M., Bendtzen, K., Frederiksen, J. L., Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., Stenager, E., & Koch-Henriksen, N. (2003). Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. The Lancet, 362(9391), 1184-91. https://doi.org/10.1016/S0140-6736(03)14541-2

@article{29959b006fd111db81a9000ea68e967b,

title = "Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis",

author = "\{Soelberg S{\o}rensen\}, P. and C. Ross and K.M. Clemmensen and K. Bendtzen and J.L. Frederiksen and K. Jensen and O. Kristensen and T. Petersen and S. Rasmussen and M. Ravnborg and Egon Stenager and N. Koch-Henriksen",

year = "2003",

doi = "10.1016/S0140-6736(03)14541-2",

language = "English",

volume = "362",

pages = "1184--91",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9391",

}

Soelberg Sørensen, P, Ross, C, Clemmensen, KM, Bendtzen, K, Frederiksen, JL, Jensen, K, Kristensen, O, Petersen, T, Rasmussen, S, Ravnborg, M, Stenager, E & Koch-Henriksen, N 2003, 'Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis', The Lancet, vol. 362, no. 9391, pp. 1184-91. https://doi.org/10.1016/S0140-6736(03)14541-2

TY - JOUR

T1 - Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

AU - Soelberg Sørensen, P.

AU - Ross, C.

AU - Clemmensen, K.M.

AU - Bendtzen, K.

AU - Frederiksen, J.L.

AU - Jensen, K.

AU - Kristensen, O.

AU - Petersen, T.

AU - Rasmussen, S.

AU - Ravnborg, M.

AU - Stenager, Egon

AU - Koch-Henriksen, N.

PY - 2003

Y1 - 2003

U2 - 10.1016/S0140-6736(03)14541-2

DO - 10.1016/S0140-6736(03)14541-2

M3 - Journal article

SN - 0140-6736

VL - 362

SP - 1184

EP - 1191

JO - The Lancet

JF - The Lancet

IS - 9391

ER -